Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company’s produ... Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company’s product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.43 | -19.3766937669 | 7.38 | 7.51 | 5.965 | 278008 | 6.63184974 | CS |
| 4 | -1.53 | -20.4545454545 | 7.48 | 7.83 | 5.965 | 257286 | 6.89321953 | CS |
| 12 | -1.51 | -20.2412868633 | 7.46 | 8.13 | 5.965 | 213585 | 7.1297918 | CS |
| 26 | 0.01 | 0.16835016835 | 5.94 | 9.32 | 5.8726 | 208362 | 7.60213113 | CS |
| 52 | 2.0587 | 52.9051987768 | 3.8913 | 9.32 | 3.85 | 140404 | 7.14324127 | CS |
| 156 | 2.4 | 67.6056338028 | 3.55 | 9.32 | 2.2 | 73181 | 6.70245114 | CS |
| 260 | 2.4 | 67.6056338028 | 3.55 | 9.32 | 2.2 | 73181 | 6.70245114 | CS |
Lacey1
7分前
train21
8分前
juicyjuice10002
9分前
Green Leaf Smoker
14分前
IhidfromtheX
16分前
train21
17分前
shadolane
19分前
mascale
23分前
mascale
23分前
BIOChecker4
25分前
Nelson2
27分前
The Truth Hurts
27分前
train21
33分前
prowler3701
36分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。